You have 9 free searches left this month | for more free features.

Diabetic Peripheral Neuropathy

Showing 9926 - 9950 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Coronary Syndrome Trial in Seoul (Ticagrelor, Prasugrel)

Completed
  • Acute Coronary Syndrome
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Apr 24, 2019

Non-Squamous NSCLC Trial in Worldwide (Atezolizumab, Docetaxel)

Completed
  • Non-Squamous Non-Small Cell Lung Cancer
  • Bakersfield, California
  • +207 more
Dec 6, 2019

Clinical Algorithm With Turbo-Power Following Treatment of

Completed
  • Peripheral Arterial Disease
  • Laser Atherectomy
  • Raleigh, North Carolina
    Rex Hospital
Jul 17, 2019

Osteoporosis Pseudoglioma Trial in Lancaster (Lithium)

Completed
  • Osteoporosis Pseudoglioma
  • Lancaster, Pennsylvania
    University of Maryland Amish Research Clinic
Oct 31, 2019

Pain Trial in Ankara (Distraction)

Completed
  • Pain
  • Distraction
  • Ankara, Turkey
    Ayla Demirtas
May 8, 2019

Fibrocytes in Early and Longstanding Rheumatoid Arthritis

Completed
  • Rheumatoid Arthritis
  • Synovial biopsy
  • Odense, Denmark
    Odense University Hospital
Mar 11, 2019

NSCLC Trial in Worldwide (INC280, Gefitinib)

Completed
  • Non-small Cell Lung Cancer
  • Woolloongabba, Queensland, Australia
  • +30 more
Mar 12, 2021

Cutaneous Lupus Erythematosus (CLE) Trial in Philadelphia (Lenalidomide)

Completed
  • Cutaneous Lupus Erythematosus (CLE)
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania, Department of Dermat
Oct 24, 2019

Immune Response After Pancreatic Cancer Treatment

Terminated
  • Pancreatic Cancer
  • irreversible electroporation (IRE)
  • Bern, Switzerland
    Inselhospital
Feb 25, 2020

Sickle Cell Disease Trial in Washington, Bethesda (Niacin-ER, Placebo, L-NMMA)

Completed
  • Sickle Cell Disease
  • Washington, District of Columbia
  • +1 more
Sep 3, 2020

Type 2 Diabetes Trial in Seongnam (Initial triple combination, Conventional treatment)

Completed
  • Type 2 Diabetes
  • Initial triple combination
  • Conventional treatment
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Mar 14, 2019

Macular Edema, Diabetic Trial in Jinju, Busan, Daegu (aflibercept)

Unknown status
  • Macular Edema, Diabetic
  • Jinju, Gyeongsangnam-do, Korea, Republic of
  • +7 more
Feb 27, 2019

Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)

Completed
  • Chronic Myeloproliferative Disorders
  • Secondary Myelofibrosis
  • Rochester, Minnesota
    Mayo Clinic
Dec 16, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Chronic Lymphocytic Leukemia Trial in Houston (Lenalidomide)

Completed
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 29, 2020

Chemerin and Fibroblast Growth Factor 21 as Biomarkers of

Completed
  • Periodontal Disease (Diagnosis)
  • Diabetes Mellitus, Type 2
  • gingival crevicular fluid level
  • Cairo, Egypt
    Faculty of Dentistry
Jul 12, 2019

Lumbar Spinal Stenosis Trial in Puerto Rico, United States (Non-randomized ACADIA® Facet Replacement System, Randomized ACADIA®

Completed
  • Lumbar Spinal Stenosis
  • Non-randomized ACADIA® Facet Replacement System
  • +2 more
  • Beverly Hills, California
  • +28 more
Aug 24, 2020

Diabetic Macular Edema Trial in United States (Dexamethasone intravitreal implant (0.7 mg), Intravitreal anti-VEGF injection)

Completed
  • Diabetic Macular Edema
  • Dexamethasone intravitreal implant (0.7 mg)
  • Intravitreal anti-VEGF injection
  • Bakersfield, California
  • +3 more
Jan 29, 2019

Diabetic Foot Ulcer Trial in India (Esmolol Hydrochloride, Only Standard of Care, Vehicle Gel)

Unknown status
  • Diabetic Foot Ulcer
  • Esmolol Hydrochloride
  • +2 more
  • Bangalore, Karnataka, India
  • +7 more
Jun 25, 2019

Onychomycosis Trial in United States (VT-1161, Placebo)

Completed
  • Onychomycosis
  • Birmingham, Alabama
  • +32 more
Oct 9, 2020

Critical Limb Ischemia Trial in Los Angeles (Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg

Unknown status
  • Critical Limb Ischemia
  • Evolocumab 140mg/mL Injector 1milliliter (mL) Pen x 3 for a monthly dose of 420 mg for 12 months.
  • Placebo 1 milliliter (mL) Injector Pen x 3 monthly for 12 months
  • Los Angeles, California
    University of Southern California
Mar 9, 2020

Achieving SDAI Remission on Joint Space Outcomes Progression in

Not yet recruiting
  • Rheumatoid Arthritis
  • Treat to target
  • (no location specified)
Mar 27, 2020

Agitation on Recovery From Sedation Trial (Hydroxyzine Hydrochloride, Alprazolam tablet, Placebo)

Unknown status
  • Agitation on Recovery From Sedation
  • Hydroxyzine Hydrochloride
  • +2 more
  • (no location specified)
Dec 4, 2019

Solid Tumors Trial in Kashiwa, Shizuoka (MSC2156119J)

Completed
  • Solid Tumors
  • Kashiwa, Japan
  • +1 more
Jul 23, 2020

Adrenomyeloneuropathy Trial in L'Hospitalet de LLobregat (N-acetylcysteine, lipoic acid, vitamin E)

Completed
  • Adrenomyeloneuropathy
  • L'Hospitalet de LLobregat, Barcelona, Spain
    Hospital Universitari de Bellvitge
Mar 7, 2019